EMAMILTDBSEEmami Ltd-$HighNeutral
Announced Thu, 21 May · 14:10 IST

Re-appointment of Shri H. V. Agarwal, subject to the approval of the shareholders at the ensuing AGM.

Management Changes View source PDF

EMAMILTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.7%1-day move
₹427.05
prior close
₹410.65
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+0.7+0.4+0.9-5.7-5.3-5.2-6.2-6.5-8.3-8.5-4.8-6.1
Up moveDown movePending
AI summary

Emami Limited's Board meeting on 21st May 2026 approved the audited consolidated financial results for Q4 and FY ended March 2026. Full-year consolidated revenue stood at ₹3,77,951 Lacs (vs ₹3,80,919 Lacs prior year), a marginal decline. PAT for FY26 was ₹77,526 Lacs vs ₹80,274 Lacs in FY25, with EPS of ₹17.76. The Board also approved the re-appointment of Shri Harsha Vardhan Agarwal (DIN: 00150089) as Vice-Chairman & Managing Director for a further 5 years after his current term ends on 31st March 2027, subject to shareholder approval at the 43rd AGM on 25th August 2026. Cost auditors M/s. V. K. Jain & Co were also re-appointed for FY27. Additionally, the company announced two acquisitions post-year-end: Axiom Ayurveda Pvt. Ltd (full stake up to ₹200 crores) and IncNut Digital Pvt. Ltd (60% stake for up to ₹321 crores).

Likely market impact

The re-appointment of the Vice-Chairman & Managing Director is a continuity signal, providing stability to the leadership. The slight revenue and profit decline in FY26 may create mild headwinds for the stock, but the announced acquisitions signal growth intent. Shareholder approval at AGM is routine.